APA

Pönisch W., Rozanski M., Goldschmidt H., Hoffmann F. A., Boldt T., Schwarzer A., Ritter U., Rohrberg R., Schwalbe E., Uhlig J., Zehrfeld T., Schirmer V., Haas A., Kreibich U. & Niederwieser D. (20081217). Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial. : British journal of haematology.

Chicago

Pönisch Wolfram, Rozanski Marta, Goldschmidt Hartmut, Hoffmann Franz Albert, Boldt Thomas, Schwarzer Andreas, Ritter Ute, Rohrberg Robert, Schwalbe Elke, Uhlig Jens, Zehrfeld Thomas, Schirmer Veronika, Haas Antje, Kreibich Ute and Niederwieser Dietger. 20081217. Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial. : British journal of haematology.

Harvard

Pönisch W., Rozanski M., Goldschmidt H., Hoffmann F. A., Boldt T., Schwarzer A., Ritter U., Rohrberg R., Schwalbe E., Uhlig J., Zehrfeld T., Schirmer V., Haas A., Kreibich U. and Niederwieser D. (20081217). Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial. : British journal of haematology.

MLA

Pönisch Wolfram, Rozanski Marta, Goldschmidt Hartmut, Hoffmann Franz Albert, Boldt Thomas, Schwarzer Andreas, Ritter Ute, Rohrberg Robert, Schwalbe Elke, Uhlig Jens, Zehrfeld Thomas, Schirmer Veronika, Haas Antje, Kreibich Ute and Niederwieser Dietger. Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial. : British journal of haematology. 20081217.